Neutropenia and febrile neutropenia (FN) are common complications of myelosuppressive
chemotherapy. This review provides an up-to-date assessment of the patient and cost …

Reducing avoidable antimicrobial exposure to pediatric patients with cancer is achievable
and necessary to promote optimal short-and long-term outcomes. Multiple evidence-based …

Background Children with cancer are at risk of critical disease and mortality from COVID-19
infection. In this study, we describe the clinical characteristics of pediatric patients with …

Objective To collate and critically review international evidence on the direct health system
costs of children and adolescents and young adults (AYA) with cancer. Methods We …

Objetivo: Comprender el significado que atribuyen los padres y madres a la experiencia de
estar junto a su hijo hospitalizado en una unidad de oncología de un hospital público de …

OBJECTIVES: We examined the trends in the rate of Henoch-Schönlein purpura (HSP)
hospitalizations and the associated resource use among children in the United States from …

Evaluation and management of fever in children with chemotherapy-induced neutropenia
are reviewed here. The types of infections and management of fever in the child with other …

OBJECTIVES To explore trends in hospitalization rate, resource use, and outcomes of
Kawasaki Disease (KD) in children in the United States from 2008 to 2017. METHODS This …

Introduction Febrile neutropenia (FN) is one of the complications of chemotherapy that can
increase the risk of infection and mortality. Granulocyte colony-stimulating factors (G-CSFs) …

Febrile neutropenia is the most common reason for admission from the emergency
department for pediatric oncology patients. We identified pediatric inpatients age 1 to 21 …